Šupe, S., Božina, N., Matijević, V., Bazina, A., Mišmaš, A., Ljevak, J. ... Poljaković, Z. (2014). Prevalence of genetic polymorphisms of CYP2C9 and VKORC1 - implications for warfarin management and outcome in Croatian patients with acute stroke. Journal of the Neurological Sciences, 343. (1-2), 30-35. doi: 10.1016/j.jns.2014.04.039
Šupe, Svjetlana, et al. "Prevalence of genetic polymorphisms of CYP2C9 and VKORC1 - implications for warfarin management and outcome in Croatian patients with acute stroke." Journal of the Neurological Sciences, vol. 343, no. 1-2, 2014, pp. 30-35. https://doi.org/10.1016/j.jns.2014.04.039
Šupe, Svjetlana, Nada Božina, Vesna Matijević, Antonela Bazina, Antonija Mišmaš, Josip Ljevak, Domagoj Alvir, Mario Habek and Zdravka Poljaković. "Prevalence of genetic polymorphisms of CYP2C9 and VKORC1 - implications for warfarin management and outcome in Croatian patients with acute stroke." Journal of the Neurological Sciences 343, no. 1-2 (2014): 30-35. https://doi.org/10.1016/j.jns.2014.04.039
Šupe, S., et al. (2014) 'Prevalence of genetic polymorphisms of CYP2C9 and VKORC1 - implications for warfarin management and outcome in Croatian patients with acute stroke', Journal of the Neurological Sciences, 343(1-2), pp. 30-35. doi: 10.1016/j.jns.2014.04.039
Šupe S, Božina N, Matijević V, Bazina A, Mišmaš A, Ljevak J, and sur.. Prevalence of genetic polymorphisms of CYP2C9 and VKORC1 - implications for warfarin management and outcome in Croatian patients with acute stroke. Journal of the Neurological Sciences [Internet]. 2014 August 15 [cited 2024 September 06];343(1-2):30-35. doi: 10.1016/j.jns.2014.04.039
S. Šupe, et al., "Prevalence of genetic polymorphisms of CYP2C9 and VKORC1 - implications for warfarin management and outcome in Croatian patients with acute stroke", Journal of the Neurological Sciences, vol. 343, no. 1-2, pp. 30-35, August 2014. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:948851. [Accessed: 06 September 2024]